Details for Patent: 7,939,502

✉ Email this page to a colleague

Summary for Patent: 7,939,502

Title:	Optimised formulation of tobramycin for aerosolization
Abstract:	The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium Pseudomonas aeruginosa associated to lung diseases such as cystic fibrosis.
Inventor(s):	Malvolti; Chiara (Parma, IT), Garzia; Raffaella (Parma, IT)
Assignee:	Chiesi Farmaceutici S.p.A. (Parma, IT)
Application Number:	12/642,336
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,939,502
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 7,939,502

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,939,502

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	01116071	Jul 02, 2001

International Family Members for US Patent 7,939,502

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1273292	⤷ Sign Up	C01273292/01	Switzerland	⤷ Sign Up
Austria	267591	⤷ Sign Up
Australia	2002319226	⤷ Sign Up
Bulgaria	108475	⤷ Sign Up
Bulgaria	66328	⤷ Sign Up
Brazil	0211320	⤷ Sign Up
Brazil	PI0211320	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.